Developer of a molecular blood test to take advantage of the freely circulating fetal DNA in the maternal bloodstream designed to determine whether the fetus has any genetic disorders. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize signal-to-noise ratio, thereby making it possible to detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy and cystic fibrosis through a simple blood test.